APOA2 and diabetes mellitus: In the present and previous studies [6, 27–29], we suggested that the blood concentration of apoA2-ATQ/AT is associated with not only early-stage PDAC, but also IPMN with a high-risk phenotype for pancreatic cancer and diabetes mellitus.